• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体途径:糖尿病肾病患者心血管疾病的风险分子模式。

Complement pathway: Risk molecular pattern of cardiovascular diseases in patients with diabetic nephropathy.

作者信息

Liu JunFei, Qian XiaoPing, Wang TaoXia, Liu XiaoLi, Liu WeiGang, Wang LiJie, Zhang HuiFang, Han Li, Li GuiYing, Yu XiaoJuan

机构信息

Affiliated Hospital of Hebei University of Engineering, Department of Nephrology, The Key Laboratory of Basic Research on Blood Purification Application in Hebei Province, Handan City, Hebei Province, China.

Affiliated Hospital of Hebei University of Engineering, Department of Nutrition, Handan City, Hebei Province, China.

出版信息

J Med Biochem. 2025 Jul 4;44(4):801-807. doi: 10.5937/jomb0-56221.

DOI:10.5937/jomb0-56221
PMID:40837356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12363369/
Abstract

BACKGROUND

Among individuals with diabetes mellitus, diabetic nephropathy (DN) is a common microvascular complication. As renal dysfunction progresses in DN patients, the risk of cardiovascular disease (CVD) significantly increases. The current effective treatment of DN and CVD demands identifying and managing their risk factors.

METHODS

Patients diagnosed with DN from October 2022 to October 2023 were selected for cross-sectional study and divided into DN group (n=58) and DN/CVD group (n=40) based on the presence of CVD. Univariate analysis was conducted using clinical data, and statistically significant independent variables were analysed through multivariate Logistic regression to identify independent factors influencing CVD in DN patients. A regression model was developed to examine the non-linear relationship between C1q, UA, CRP, and the risk of CVD. The receiver operating characteristic curve was used to analyse the predictive efficacy of the indicators.

RESULTS

When elevated, UA and C1q were independent factors for CVD. A linear relationship existed between UA and C1q and the risk of CVD in DN patients. C1q showed better predictive performance.

CONCLUSIONS

As UA and C1q levels rise, the risk of CVD in DN patients significantly increases. In DN patients, UA and C1q are associated with CVD development and progression, offering some supportive evaluation value for the patient's condition.

摘要

背景

在糖尿病患者中,糖尿病肾病(DN)是一种常见的微血管并发症。随着DN患者肾功能障碍的进展,心血管疾病(CVD)的风险显著增加。目前对DN和CVD的有效治疗需要识别和管理其危险因素。

方法

选取2022年10月至2023年10月诊断为DN的患者进行横断面研究,并根据是否存在CVD分为DN组(n = 58)和DN/CVD组(n = 40)。使用临床数据进行单因素分析,并通过多因素Logistic回归分析具有统计学意义的独立变量,以确定影响DN患者CVD的独立因素。建立回归模型以检验C1q、尿酸(UA)、C反应蛋白(CRP)与CVD风险之间的非线性关系。采用受试者工作特征曲线分析各指标的预测效能。

结果

UA和C1q升高时是CVD的独立因素。DN患者中UA和C1q与CVD风险之间存在线性关系。C1q显示出更好的预测性能。

结论

随着UA和C1q水平升高,DN患者发生CVD的风险显著增加。在DN患者中,UA和C1q与CVD的发生和进展相关,对患者病情具有一定的支持性评估价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cba/12363369/8768042cfa89/jomb-44-4-2504801L_g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cba/12363369/ee92578f9662/jomb-44-4-2504801L_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cba/12363369/8768042cfa89/jomb-44-4-2504801L_g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cba/12363369/ee92578f9662/jomb-44-4-2504801L_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cba/12363369/8768042cfa89/jomb-44-4-2504801L_g002.jpg

相似文献

1
Complement pathway: Risk molecular pattern of cardiovascular diseases in patients with diabetic nephropathy.补体途径:糖尿病肾病患者心血管疾病的风险分子模式。
J Med Biochem. 2025 Jul 4;44(4):801-807. doi: 10.5937/jomb0-56221.
2
Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China.2型糖尿病患者血清肿瘤标志物与糖尿病肾病的关联:中国西部的一项横断面调查
BMC Endocr Disord. 2025 Jul 1;25(1):150. doi: 10.1186/s12902-025-01932-1.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Non-Invasive Diagnosis and Monitoring of Diabetic Nephropathy: Assessment of Renal Function and Fibrosis by Diffusion Kurtosis Imaging.糖尿病肾病的非侵入性诊断与监测:通过扩散峰度成像评估肾功能和纤维化
Int J Gen Med. 2025 Jul 21;18:4011-4026. doi: 10.2147/IJGM.S517683. eCollection 2025.
5
Expression and diagnostic value evaluation of urinary exosomal miR-142-3p in diabetic nephropathy.尿外泌体miR-142-3p在糖尿病肾病中的表达及诊断价值评估
Sci Rep. 2025 Jul 4;15(1):23991. doi: 10.1038/s41598-025-06002-z.
6
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
7
[Interaction of α-amylase and inflammatory response in patients with ventilator-associated pneumonia and their prognostic value].[α-淀粉酶与呼吸机相关性肺炎患者炎症反应的相互作用及其预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):535-541. doi: 10.3760/cma.j.cn121430-20240409-00321.
8
Discordance of diabetic retinopathy severity in a cohort of diabetic nephropathy patients: a cross-sectional case-control study in a new Mexican population of type 2 diabetes.一组糖尿病肾病患者中糖尿病视网膜病变严重程度的不一致性:一项针对新墨西哥州2型糖尿病患者群体的横断面病例对照研究
Front Endocrinol (Lausanne). 2025 Aug 1;16:1638415. doi: 10.3389/fendo.2025.1638415. eCollection 2025.
9
Association between serum spexin levels and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study.2型糖尿病患者血清Spexin水平与糖尿病肾病的关系:一项横断面研究。
Int Urol Nephrol. 2025 May 10. doi: 10.1007/s11255-025-04556-5.
10
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.

本文引用的文献

1
Complement: Functions, location and implications.补体:功能、定位和意义。
Immunology. 2023 Oct;170(2):180-192. doi: 10.1111/imm.13663. Epub 2023 May 24.
2
Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020.2015 - 2020年糖尿病成年患者慢性肾脏病的发病率
N Engl J Med. 2022 Oct 13;387(15):1430-1431. doi: 10.1056/NEJMc2207018.
3
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.
在接受 SGLT2 抑制剂治疗的急性心肌梗死合并糖尿病患者中,梗死面积、炎症负担和入院高血糖。一项多中心国际注册研究。
Cardiovasc Diabetol. 2022 May 15;21(1):77. doi: 10.1186/s12933-022-01506-8.
4
Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome.经典补体 C1q 表达增强与动脉粥样硬化进展和斑块不稳定性有关:C1q 作为临床转归的标志物。
PLoS One. 2022 Jan 27;17(1):e0262413. doi: 10.1371/journal.pone.0262413. eCollection 2022.
5
Activation of complement C1q and C3 in glomeruli might accelerate the progression of diabetic nephropathy: Evidence from transcriptomic data and renal histopathology.补体 C1q 和 C3 在肾小球中的激活可能加速糖尿病肾病的进展:来自转录组数据和肾脏组织病理学的证据。
J Diabetes Investig. 2022 May;13(5):839-849. doi: 10.1111/jdi.13739. Epub 2022 Jan 10.
6
Serum Complement C1q Activity Is Associated With Obstructive Coronary Artery Disease.血清补体C1q活性与阻塞性冠状动脉疾病相关。
Front Cardiovasc Med. 2021 Apr 29;8:618173. doi: 10.3389/fcvm.2021.618173. eCollection 2021.
7
Complement-mediated kidney diseases.补体介导的肾脏疾病。
Mol Immunol. 2020 Dec;128:175-187. doi: 10.1016/j.molimm.2020.10.015. Epub 2020 Nov 1.
8
Glucocorticoids in COVID19; a friend not foe.新冠疫情中的糖皮质激素:益友而非劲敌
J Res Med Sci. 2020 May 22;25:45. doi: 10.4103/jrms.JRMS_331_20. eCollection 2020.
9
Serum complement C1q level is associated with acute coronary syndrome.血清补体 C1q 水平与急性冠状动脉综合征相关。
Mol Immunol. 2020 Apr;120:130-135. doi: 10.1016/j.molimm.2020.02.012. Epub 2020 Feb 28.
10
Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice.阻断 STAT3 在肾小管上皮细胞中的作用可预防 STZ 诱导的糖尿病小鼠的肾脏纤维化和肾病。
Cell Death Dis. 2019 Nov 7;10(11):848. doi: 10.1038/s41419-019-2085-0.